Revision as of 01:07, 1 September 2011 editBogBot (talk | contribs)Bots53,132 edits populated new fields in {{drugbox}} and reordered per bot approval. Report errors and suggestions to User_talk:BogBot← Previous edit |
Latest revision as of 14:10, 8 February 2024 edit undoVastV0idInSpace0 (talk | contribs)Extended confirmed users2,343 edits Fixed spacing between stub template and category templates.Tag: 2017 wikitext editor |
(22 intermediate revisions by 22 users not shown) |
Line 1: |
Line 1: |
|
|
{{Short description|Chemical compound}} |
|
{{Drugbox |
|
{{Drugbox |
|
⚫ |
| verifiedrevid = 447764085 |
|
| Verifiedfields = changed |
|
|
| Watchedfields = changed |
|
⚫ |
| verifiedrevid = 399924353 |
|
|
| IUPAC_name = ''N''-ethyl-''N''-methyl-4,4-dithiophen-2-yl-but-3-en-2-amine |
|
| IUPAC_name = ''N''-ethyl-''N''-methyl-4,4-dithiophen-2-yl-but-3-en-2-amine |
|
| image = Ethylmethylthiambutene structure.svg |
|
| image = Ethylmethylthiambutene structure.svg |
Line 13: |
Line 12: |
|
| pregnancy_category = |
|
| pregnancy_category = |
|
| legal_AU = |
|
| legal_AU = |
|
| legal_CA = |
|
| legal_BR = A1 |
|
|
| legal_BR_comment = <ref>{{Cite web |author=Anvisa |author-link=Brazilian Health Regulatory Agency |date=2023-03-31 |title=RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial |trans-title=Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control|url=https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992 |url-status=live |archive-url=https://web.archive.org/web/20230803143925/https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992 |archive-date=2023-08-03 |access-date=2023-08-16 |publisher=] |language=pt-BR |publication-date=2023-04-04}}</ref> |
|
|
| legal_CA = Schedule I |
|
| legal_US = Schedule I |
|
| legal_US = Schedule I |
|
| legal_status = |
|
| legal_DE = Anlage I |
|
| routes_of_administration = |
|
| routes_of_administration = |
|
|
|
|
|
<!--Pharmacokinetic data--> |
|
<!--Pharmacokinetic data--> |
Line 23: |
Line 24: |
|
| metabolism = |
|
| metabolism = |
|
| elimination_half-life = |
|
| elimination_half-life = |
|
| excretion = |
|
| excretion = |
|
|
|
|
|
<!--Identifiers--> |
|
<!--Identifiers--> |
Line 30: |
Line 31: |
|
| ATC_suffix = |
|
| ATC_suffix = |
|
| PubChem = 46424 |
|
| PubChem = 46424 |
|
| DrugBank_Ref = {{drugbankcite|changed|drugbank}} |
|
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
|
| DrugBank = DB01468 |
|
| DrugBank = DB01468 |
|
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|
| ChemSpiderID = 42256 |
|
| ChemSpiderID = 42256 |
|
| UNII_Ref = {{fdacite|changed|FDA}} |
|
| UNII_Ref = {{fdacite|correct|FDA}} |
|
| UNII = 722BFZ899Q |
|
| UNII = 722BFZ899Q |
|
|
| KEGG_Ref = {{keggcite|correct|kegg}} |
|
|
| KEGG = D12663 |
|
|
|
|
|
<!--Chemical data--> |
|
<!--Chemical data--> |
|
| C=15 | H=19 | N=1 | S=2 |
|
| C=15 | H=19 | N=1 | S=2 |
|
| molecular_weight = 277.45 g/mol |
|
|
| smiles = CCN(C)C(C)C=C(C1=CC=CS1)C2=CC=CS2 |
|
| smiles = CCN(C)C(C)C=C(C1=CC=CS1)C2=CC=CS2 |
|
| InChI = 1/C15H19NS2/c1-4-16(3)12(2)11-13(14-7-5-9-17-14)15-8-6-10-18-15/h5-12H,4H2,1-3H3 |
|
|
| InChIKey = MORSAEFGQPDBKM-UHFFFAOYAM |
|
|
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
|
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
|
| StdInChI = 1S/C15H19NS2/c1-4-16(3)12(2)11-13(14-7-5-9-17-14)15-8-6-10-18-15/h5-12H,4H2,1-3H3 |
|
| StdInChI = 1S/C15H19NS2/c1-4-16(3)12(2)11-13(14-7-5-9-17-14)15-8-6-10-18-15/h5-12H,4H2,1-3H3 |
Line 51: |
Line 51: |
|
}} |
|
}} |
|
|
|
|
|
'''Ethylmethylthiambutene''' (''N''-ethyl-''N''-methyl-1-methyl-3,3-di-2-thienylallylamine, Emethibutin) is an ] ] drug from the ] family, around 1.3x the potency of ].<ref>{{cite journal | last1 = Adamson | first1 = DW | last2 = Green | first2 = AF | title = A new series of analgesics | journal = Nature | volume = 165 | issue = 4186 | pages = 122–122 | year = 1950 | pmid = 15409854 | doi = 10.1038/165122a0 }}</ref><ref>{{cite journal | last1 = Adamson | first1 = DW | last2 = Duffin | first2 = WM | last3 = Green | first3 = AF | title = Dithienylbutylamines as analgesics | journal = Nature | volume = 167 | issue = 4239 | pages = 153–4 | year = 1951 | pmid = 14806409 | doi = 10.1038/167153b0 }}</ref><ref>{{cite journal | last1 = Green | first1 = AF | title = Analgesic and other properties of 3: 3-dithienylalkenylamines | journal = British journal of pharmacology and chemotherapy | volume = 8 | issue = 1 | pages = 2–9 | year = 1953 | pmid = 13066683 | pmc = 1509239 }}</ref> It is under international control under Schedule I of the UN Single Convention On Narcotic Drugs 1961, presumably due to high abuse potential. |
|
'''Ethylmethylthiambutene''' ({{not a typo|''N''-ethyl-''N''-methyl-1-methyl-3,3-di-2-thienylallylamine}}; '''Emethibutin''') is an ] ] drug from the ] family, around 1.3x the potency of ].<ref>{{cite journal | vauthors = Adamson DW, Green AF | s2cid = 4190157 | title = A new series of analgesics | journal = Nature | volume = 165 | issue = 4186 | pages = 122 | date = January 1950 | pmid = 15409854 | doi = 10.1038/165122a0 | bibcode = 1950Natur.165..122A | doi-access = free }}</ref><ref>{{cite journal | vauthors = Adamson DW, Duffin WM, Green AF | s2cid = 4280042 | title = Dithienylbutylamines as analgesics | journal = Nature | volume = 167 | issue = 4239 | pages = 153–4 | date = January 1951 | pmid = 14806409 | doi = 10.1038/167153b0 | bibcode = 1951Natur.167..153A }}</ref><ref>{{cite journal | vauthors = Green AF | title = Analgesic and other properties of 3: 3-dithienylalkenylamines | journal = British Journal of Pharmacology and Chemotherapy | volume = 8 | issue = 1 | pages = 2–9 | date = March 1953 | pmid = 13066683 | pmc = 1509239 | doi = 10.1111/j.1476-5381.1953.tb00739.x }}</ref> It is under international control under Schedule I of the UN Single Convention On Narcotic Drugs 1961, presumably due to high abuse potential. |
|
|
|
|
|
It is a Schedule I controlled substance in the United States with a DEA ACSCN of 9623 and zero annual manufacturing quota as of 2013.{{citation needed|date=June 2014}} |
|
|
|
|
|
==References== |
|
== References == |
|
{{Reflist}} |
|
{{Reflist}} |
|
|
|
|
|
{{Analgesics}} |
|
|
{{Opioidergics}} |
|
|
|
|
|
] |
|
] |
|
] |
|
] |
|
] |
|
] |
|
] |
|
] |
|
|
|
|
⚫ |
{{analgesic-stub}} |
|
|
|
|
|
|
⚫ |
{{analgesic-stub}} |
|
] |
|